Lanean...
Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19
Preexisting hypertension is a known risk factor for severe COVID-19. Abnormal activation of RAS upregulates angiotensin II (Ang-II) and contributes to severe manifestations of COVID-19. Although RAS inhibitors (RASi) are a mainstay of antihypertensive therapy, they have been associated (in some anim...
Gorde:
| Argitaratua izan da: | Med Hypotheses |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier Ltd.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8114589/ https://ncbi.nlm.nih.gov/pubmed/34048987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2021.110609 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|